Eppendorf and BioLabs Expand Collaboration to Support Biotech Innovation in Munich

Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, and BioLabs, a global innovation infrastructure company creating the physical and community backbone that powers life science discovery worldwide, today announced the expansion of their collaboration to BioLabs’ new Munich site, BioLabs | TUM, extending a relationship that already includes BioLabs locations in the U.S, France and Germany. The partnership will provide biotech and life-science entrepreneurs with access to laboratory equipment, technical expertise and a connected innovation community.

Eppendorf and BioLabs Expand Collaboration to Support Biotech Innovation in Munich
Opening of BioLabs | TUM. From left to right: Dr. Johannes Fruehauf, CEO BioLabs, Dr. Max Pöhlmann, Site Director, BioLabs TUM, Dr. Floris Engelhardt, CEO/CSO & Co-Founder Kano Therapeutics, Dr. Philipp Gerbert, CEO TUM Venture Labs, Johanna Michielin, Regional Director, BioLabs Europe. Image Credit: Eppendorf

Under the partnership, Eppendorf will participate as a Gold Sponsor of BioLabs | TUM in Munich. The collaboration reflects a shared commitment to strengthening the life-science ecosystem: BioLabs provides the space, community and operational environment in which startups can develop, while Eppendorf contributes laboratory technologies and expertise that support day-to-day research and growth, including providing instrumentation and related software, staff training programs, and equipment maintenance, as well as delivering lectures and conferences. The site will provide opportunities for workshops, office hours, on-site events and other engagement activities for BioLabs’ resident companies.

Located within Munich’s dynamic innovation ecosystem, BioLabs | TUM began welcoming residents earlier this summer. The site provides shared and private laboratory spaces, offices, operational support and access to a community of entrepreneurs, mentors, investors and industry partners. It is designed to support the continued growth of the region’s life-science ecosystem in connection with the broader TUM Venture Labs.

Expanding our collaboration with BioLabs to the new Munich site allows us to bring Eppendorf’s equipment and expertise closer to a new generation of biotech companies. The partnership combines practical support for laboratories with opportunities for direct exchange between Eppendorf and the companies shaping the future of life science.”

Axel Ziemke, Vice President Central Area EMEA, Eppendorf Vertrieb Deutschland GmbH

“BioLabs’ partnership with Eppendorf spans more than a decade, and we are very proud to extend this long-standing collaboration to Munich,” said Johannes Fruehauf, CEO and Founder of BioLabs. “Our mission is to support entrepreneurs and innovative scientists as they bring breakthrough ideas to life, and we are confident that Eppendorf shares that commitment. We are excited to have Eppendorf join us in supporting the next generation of life-science companies in Munich and look forward to building on our collaboration in this important ecosystem.”

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Eppendorf SE. (2026, October 22). Eppendorf and BioLabs Expand Collaboration to Support Biotech Innovation in Munich. AZoLifeSciences. Retrieved on October 22, 2026 from https://www.azolifesciences.com/news/20261022/Eppendorf-and-BioLabs-Expand-Collaboration-to-Support-Biotech-Innovation-in-Munich.aspx.

  • MLA

    Eppendorf SE. "Eppendorf and BioLabs Expand Collaboration to Support Biotech Innovation in Munich". AZoLifeSciences. 22 October 2026. <https://www.azolifesciences.com/news/20261022/Eppendorf-and-BioLabs-Expand-Collaboration-to-Support-Biotech-Innovation-in-Munich.aspx>.

  • Chicago

    Eppendorf SE. "Eppendorf and BioLabs Expand Collaboration to Support Biotech Innovation in Munich". AZoLifeSciences. https://www.azolifesciences.com/news/20261022/Eppendorf-and-BioLabs-Expand-Collaboration-to-Support-Biotech-Innovation-in-Munich.aspx. (accessed October 22, 2026).

  • Harvard

    Eppendorf SE. 2026. Eppendorf and BioLabs Expand Collaboration to Support Biotech Innovation in Munich. AZoLifeSciences, viewed 22 October 2026, https://www.azolifesciences.com/news/20261022/Eppendorf-and-BioLabs-Expand-Collaboration-to-Support-Biotech-Innovation-in-Munich.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.